Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Clemente-Surez VJ, Beltrn-Velasco AI, Redondo-Flrez L, Martn-Rodrguez A, Tornero-Aguilera JF
additional contraceptive methods are advised for 4 weeks after starting treatment and after each dose increase Patients with severe gastrointestinal disease (e.g., gastroparesis) should generally avoid Mounjaro If the patient is on insulin, doses should not be rapidly reduced when starting Mounjaro, as this increases the risk of diabetic ketoacidosis Patients should be counselled to report symptoms suggestive of thyroid C-cell tumours (neck mass, difficulty swallowing, persistent hoarseness) A collaborative approach involving endocrinologists, GPs, and diabetes specialists is often beneficial to ensure comprehensive care and monitoring
In a cohort of over 150,000 patients, the researchers identified no difference in the risk following initiation of different GLP-1 agents among these adults, despite the differences in systemic efficacy among the examined GLP-1 receptor agonist medications
This removes all guesswork later
For a deeper look at when it may or may not be necessary, read more about whether HCG is necessary on TRT
